Cargando…

Advances in the treatment of hepatogenous diabetes: A review

Hepatogenous diabetes (HD) is a glycogen metabolism disorder that arises as a consequence of chronic liver disease. The condition is frequently detected in patients diagnosed with cirrhosis, which is a result of advanced liver disease. The prognosis for patients with HD is generally poor, and they a...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Yanru, Li, Keyu, Li, Ang, Hu, WeiMing, Hu, Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10659649/
https://www.ncbi.nlm.nih.gov/pubmed/37986334
http://dx.doi.org/10.1097/MD.0000000000036068
_version_ 1785148356453990400
author Deng, Yanru
Li, Keyu
Li, Ang
Hu, WeiMing
Hu, Wen
author_facet Deng, Yanru
Li, Keyu
Li, Ang
Hu, WeiMing
Hu, Wen
author_sort Deng, Yanru
collection PubMed
description Hepatogenous diabetes (HD) is a glycogen metabolism disorder that arises as a consequence of chronic liver disease. The condition is frequently detected in patients diagnosed with cirrhosis, which is a result of advanced liver disease. The prognosis for patients with HD is generally poor, and they are at a heightened risk for serious complications such as gastrointestinal bleeding, primary peritonitis, and hepatic encephalopathy. Hepatogenous diabetes progression is often associated with cirrhosis progression, which leads to the development of liver cancer and increased patient mortality. Despite the prevalence and severity of HD, no systematic treatment strategy for clinical management of the condition has been proposed by any research or institutions to date. This paper conducts an extensive review of recent advancements in HD treatment in the quest for an effective treatment approach that may improve the overall prognosis of HD.
format Online
Article
Text
id pubmed-10659649
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-106596492023-11-17 Advances in the treatment of hepatogenous diabetes: A review Deng, Yanru Li, Keyu Li, Ang Hu, WeiMing Hu, Wen Medicine (Baltimore) 4300 Hepatogenous diabetes (HD) is a glycogen metabolism disorder that arises as a consequence of chronic liver disease. The condition is frequently detected in patients diagnosed with cirrhosis, which is a result of advanced liver disease. The prognosis for patients with HD is generally poor, and they are at a heightened risk for serious complications such as gastrointestinal bleeding, primary peritonitis, and hepatic encephalopathy. Hepatogenous diabetes progression is often associated with cirrhosis progression, which leads to the development of liver cancer and increased patient mortality. Despite the prevalence and severity of HD, no systematic treatment strategy for clinical management of the condition has been proposed by any research or institutions to date. This paper conducts an extensive review of recent advancements in HD treatment in the quest for an effective treatment approach that may improve the overall prognosis of HD. Lippincott Williams & Wilkins 2023-11-17 /pmc/articles/PMC10659649/ /pubmed/37986334 http://dx.doi.org/10.1097/MD.0000000000036068 Text en Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle 4300
Deng, Yanru
Li, Keyu
Li, Ang
Hu, WeiMing
Hu, Wen
Advances in the treatment of hepatogenous diabetes: A review
title Advances in the treatment of hepatogenous diabetes: A review
title_full Advances in the treatment of hepatogenous diabetes: A review
title_fullStr Advances in the treatment of hepatogenous diabetes: A review
title_full_unstemmed Advances in the treatment of hepatogenous diabetes: A review
title_short Advances in the treatment of hepatogenous diabetes: A review
title_sort advances in the treatment of hepatogenous diabetes: a review
topic 4300
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10659649/
https://www.ncbi.nlm.nih.gov/pubmed/37986334
http://dx.doi.org/10.1097/MD.0000000000036068
work_keys_str_mv AT dengyanru advancesinthetreatmentofhepatogenousdiabetesareview
AT likeyu advancesinthetreatmentofhepatogenousdiabetesareview
AT liang advancesinthetreatmentofhepatogenousdiabetesareview
AT huweiming advancesinthetreatmentofhepatogenousdiabetesareview
AT huwen advancesinthetreatmentofhepatogenousdiabetesareview